Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
BeOne Medicines
BeOne Medicines
Thomas Jefferson University
BeOne Medicines
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
Nurix Therapeutics, Inc.
Verismo Therapeutics
Janssen Research & Development, LLC
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
AbbVie
Calibr, a division of Scripps Research
Hackensack Meridian Health
Massachusetts General Hospital
Dana-Farber Cancer Institute
AbbVie
Ohio State University Comprehensive Cancer Center
Acerta Pharma BV
Nurix Therapeutics, Inc.